Stockreport

BioLineRx Announces First Patient Dosed in Randomized Phase 2 Combination Clinical Trial Evaluating Motixafortide in First-Line Pancreatic Cancer (PDAC) [Yahoo! Finance]

BioLineRx Ltd. - American Depositary Shares  (BLRX) 
Last biolinerx ltd. - american depositary shares earnings: 5/14 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.biolinerx.com
PDF motixafortide with a PD-1 inhibitor and first-line PDAC chemotherapies compared to chemo alone Gulam Manji , MD, PhD, of Columbia University to present encore pilot ph [Read more]